About conolidine
Andy Chevigné and his group, RTI-5152-twelve is postulated to increase the levels of opioid peptides that bind to classical opioid receptors during the brain, leading to heightened painkilling exercise. The LIH-RTI investigate teams recognized a collaboration arrangement and submitted a joint patent application in December 2020.Scientific American